8 studies found for:    18468541 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Safety and Efficacy of Allogeneic MSCs in Promoting T-regulatory Cells in Patients With Small Abdominal Aortic Aneurysms
Conditions: AAA;   Abdominal Aortic Aneurysm;   Vascular Disease;   Peripheral Artery Disease
Interventions: Biological: Intravenous infusion of Plasmalyte A (placebo);   Biological: Intravenous infusion of 1 million allogeneic MSCs/kg;   Biological: Intravenous infusion of 3 million allogeneic MSCs/kg
2 Recruiting Safety and Potential Efficacy of Human Mesenchymal Stem Cells in Non‐Cystic Fibrosis Bronchiectasis
Condition: Bronchiectasis
Intervention: Biological: hMSCs
3 Recruiting A Study of Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Biological: Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells;   Other: Liberation therapy
4 Terminated A Study of Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Biological: Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells;   Other: Liberation therapy
5 Enrolling by invitation Mesenchymal Stem Cells Co-transplantation in Alternative Donor Transplantation of Severe Aplastic Anemia.
Condition: Severe Aplastic Anemia
Intervention: Biological: mesenchymal stem cells
6 Recruiting Umbilical Cord Derived Mesenchymal Stromal Cells For The Treatment of Severe Steroid-resistant Graft Versus Host Disease
Condition: Hematologic Malignancies
Intervention: Biological: UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELLS (UC-MSC)
7 Recruiting Mesenchymal Stem Cells for Treatment of Refractory Acute Graft-versus-host Disease
Condition: Acute Graft-versus-host Disease
Interventions: Biological: Mesenchymal stem cells;   Biological: Non-mesenchymal stem cells
8 Unknown  Human Mesenchymal Stem Cells Induce Liver Transplant Tolerance
Condition: Evidence of Liver Transplantation
Interventions: Drug: Conventional plus UC-MSC;   Drug: Conventional plus placebo

Indicates status has not been verified in more than two years